Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Action inhibitors |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), RNA polymerase II inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Japan | 28 Apr 2025 | |
Neoplasms | Preclinical | Japan | 28 Apr 2025 | |
Neoplasms | Preclinical | Japan | 28 Apr 2025 |